Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial.
This multicenter, open-label, blinded-endpoint randomized clinical trial compared intravenous tenecteplase before endovascular thrombectomy (EVT) with EVT alone in patients with moderate to severe basilar artery…
Why it matters
For patients with moderate to severe basilar artery occlusion presenting in this late time window to EVT-capable centers, the trial found no functional-outcome advantage from adding intravenous tenecteplase before…